My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: Population Health and Prevention cancel Nebraska cancel Indiana cancel

States Using Policy to Reduce Dementia’s Disease and Fiscal Impact

Blog,
Health Policy Update,
Policy,
State Health Policy,
Health Equity,
Population Health and Prevention,
Chronic Disease Prevention and Health Improvement,
Healthy Aging,
Colorado,
Idaho,
Illinois,
Indiana,
Kentucky,
Maryland,
Montana,
Nebraska,
Oklahoma,
Pennsylvania,
Rhode Island,
Tennessee,
Utah,
Washington,
West Virginia,
Tyrone Bethune

Public health agencies are working to reduce dementia risk and to optimize the health and well-being of people living with dementia and their caregivers.

State Legislatures Moving to Increase Rural Healthcare Access

Blog,
Health Policy Update,
Population Health and Prevention,
Healthcare Access,
Florida,
Hawaii,
Kentucky,
Nebraska,
Iowa,
Nevada,
New Mexico,
Alabama,
Oklahoma,
Indiana,
Colorado,
North Dakota,
Mississippi,
Georgia,
California,
Oregon,
Washington

State Legislatures Moving to Increase Rural Healthcare Access How States Are Incentivizing Healthcare Providers to Practice in Rural Areas Lana McKinney Hospital closures and fewer care options in rural areas cause worse health outcomes ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...